Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star Scientific Inc., and Impax Laboratories Inc.

    Today's Research: Pharmacyclics Inc., United Therapeutics Corp., Star                  Scientific Inc., and Impax Laboratories Inc.  Editor Note: For more information about this release, please scroll to bottom  PR Newswire  LONDON, October 8, 2013  LONDON, October 8, 2013 /PRNewswire/ --  On Monday, October 7, 2013, the S&P 500 ended the day at 1,676.12, down 0.85%; the Dow Jones Industrial Average closed at 14,936.24, down 0.90%; and the NASDAQ Composite finished at 3,770.38, down 0.98%. Shares in healthcare drug makers sector mostly ended on a lower note as the broader market posted losses. The major movers in the sector include Pharmacyclics Inc. (NASDAQ: PCYC), United Therapeutics Corporation (NASDAQ: UTHR), Star Scientific Inc. (NASDAQ: STSI), and Impax Laboratories Inc. (NASDAQ: IPXL). AAAResearchReports.com has completed their technical analysis on PCYC, UTHR, STSI, and IPXL and these free reports are accessible by registering at:  http://www.aaaresearchreports.com/register/   On Monday, Pharmacyclics Inc. stock plunged. The company's shares traded between $139.00 and $132.29 before finishing the day at $135.01, which is 3.28% lower than the previous day's close of $139.59. A total of 0.82 million shares were traded which is above the daily average volume of 0.66 million. The company's shares are currently trading at 5.81% lower than the 52-week high of $143.34 and at 200.62% higher than the 52-week low of $44.91. The company's shares have lost 2.00% in the previous three trading sessions. In the last three months, the stock has surged 55.20%, outperforming the S&P 500, which has advanced 2.71% during the same period. Further, Pharmacyclics Inc.'s shares are currently trading above their 50-day and 200-day moving average of $117.68 and $90.14, respectively. Sign up for free technical research on PCYC at:  http://www.AAAResearchReports.com/PCYC100813.pdf  On Monday, United Therapeutics Corp's stock edged lower. The company's shares traded between $83.52 and $85.57 before finishing the day at $85.08, which is 0.47% lower than the previous close of $85.48. A total of 0.49 million shares were traded which is below the daily average volume of 0.48 million. The company's shares are currently trading at 0.98% lower than the 52-week high of $85.92 and at 91.15% higher than the 52-week low of $44.51. The company's shares have gained 1.69% in the previous three trading sessions. In the last three months, United Therapeutics Corp.'s stock has gained 26.59%, outperforming the S&P 500 which has advanced 2.71% during the same period. Moreover, the company's stock is currently trading above its 50-day and 200-day moving average of $75.51 and $64.76, respectively. Be sure to read our latest technical research on UTHR by registering at:  http://www.AAAResearchReports.com/UTHR100813.pdf  Star Scientific Inc.'s stock moved higher on Monday, even as the broader market declined. The company's shares fluctuated between $1.90 and $1.98 before finishing the day 0.51% up, at $1.96. A total of 0.63 million shares were traded which is below the daily average volume of 0.80 million. Star Scientific Inc.'s shares have gained 0.51% in the previous three trading sessions. In last three months, the stock has gained 27.27%, thus outperforming the S&P 500, which has advanced 2.71% during the same period. Furthermore, the company's shares are currently trading in line with its 50-day moving average and above its 200-day moving average of $1.96 and $1.83, respectively. Sign up and read the complimentary report on STSI at:  http://www.AAAResearchReports.com/STSI100813.pdf  Shares in Impax Laboratories Inc. moved lower on Monday, before finishing the day at $20.66, which is 0.82% lower than the previous day's close of $20.83. A total of 0.33 million shares were traded which is below the daily average volume of 0.42 million. The company's shares are currently trading at 22.82% lower than the 52-week high of $26.77 and at 43.37% higher than the 52-week low of $14.41. The company's shares are up 1.47% in the previous three months, underperforming the S&P 500 which has gained 2.71% during the same period. Additionally, Impax Laboratories Inc.'s stock is currently trading above its 200-day moving average of 19.23. The free report on IPXL can be downloaded by signing up now at:  http://www.AAAResearchReports.com/IPXL100813.pdf  ----  EDITOR NOTES:  1.This is not company news. We are an independent source and our views do     not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts     basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are     only human and are prone to make mistakes. If you notice any errors or     omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to     increase awareness for mentioned companies to our subscriber base and the     investing public. 4.If you wish to have your company covered in more detail by our team, or     wish to learn more about our services, please contact us at     pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at     compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your     company? Send us a full investors' package to     research@EquityNewsNetwork.com for consideration.  COMPLIANCE PROCEDURE  Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.  NOT FINANCIAL ADVICE  Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.  NO WARRANTY OR LIABILITY ASSUMED  Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.  CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.  SOURCE AAA Research Reports  Contact: Peter F. Jones; +1(646)396-9126 (North America); info@aaaresearchreports.com  
Press spacebar to pause and continue. Press esc to stop.